167 related articles for article (PubMed ID: 37180673)
1. Detection of
Omura K; Murakami Y; Hashimoto K; Takahashi H; Suzuki R; Yoshioka Y; Oguchi M; Ichinose J; Matsuura Y; Nakao M; Okumura S; Mun M
Transl Cancer Res; 2023 Apr; 12(4):837-847. PubMed ID: 37180673
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
3. Detailed identification of epidermal growth factor receptor mutations in lung adenocarcinoma: Combining radiomics with machine learning.
Li S; Luo T; Ding C; Huang Q; Guan Z; Zhang H
Med Phys; 2020 Aug; 47(8):3458-3466. PubMed ID: 32416013
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Identification of
Zhang T; Xu Z; Liu G; Jiang B; de Bock GH; Groen HJM; Vliegenthart R; Xie X
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920322
[TBL] [Abstract][Full Text] [Related]
5. Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer.
Yamazaki M; Yagi T; Tominaga M; Minato K; Ishikawa H
Br J Radiol; 2022 Dec; 95(1140):20220374. PubMed ID: 36115683
[TBL] [Abstract][Full Text] [Related]
6. Predicting EGFR mutation subtypes in lung adenocarcinoma using
Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
[TBL] [Abstract][Full Text] [Related]
7. Accurate prediction of epidermal growth factor receptor mutation status in early-stage lung adenocarcinoma, using radiomics and clinical features.
Zhu H; Song Y; Huang Z; Zhang L; Chen Y; Tao G; She Y; Sun X; Yu H
Asia Pac J Clin Oncol; 2022 Dec; 18(6):586-594. PubMed ID: 35098682
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of novel radiomics-based nomograms for the prediction of
Dong Y; Jiang Z; Li C; Dong S; Zhang S; Lv Y; Sun F; Liu S
Quant Imaging Med Surg; 2022 May; 12(5):2658-2671. PubMed ID: 35502390
[TBL] [Abstract][Full Text] [Related]
9. CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma.
Choe J; Lee SM; Kim W; Do KH; Kim S; Choi S; Seo JB
Eur J Radiol; 2021 Jun; 139():109710. PubMed ID: 33862316
[TBL] [Abstract][Full Text] [Related]
10. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
[No Abstract] [Full Text] [Related]
11. Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma.
Hong D; Xu K; Zhang L; Wan X; Guo Y
Front Oncol; 2020; 10():28. PubMed ID: 32082997
[No Abstract] [Full Text] [Related]
12. Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With
Tang X; Li Y; Yan WF; Qian WL; Pang T; Gong YL; Yang ZG
Front Oncol; 2021; 11():719919. PubMed ID: 34660285
[TBL] [Abstract][Full Text] [Related]
13. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
[TBL] [Abstract][Full Text] [Related]
14. The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma.
Zhao W; Wu Y; Xu Y; Sun Y; Gao P; Tan M; Ma W; Li C; Jin L; Hua Y; Liu J; Li M
Front Oncol; 2019; 9():1485. PubMed ID: 31993370
[No Abstract] [Full Text] [Related]
15. Radiomic Detection of EGFR Mutations in NSCLC.
Rossi G; Barabino E; Fedeli A; Ficarra G; Coco S; Russo A; Adamo V; Buemi F; Zullo L; Dono M; De Luca G; Longo L; Dal Bello MG; Tagliamento M; Alama A; Cittadini G; Pronzato P; Genova C
Cancer Res; 2021 Feb; 81(3):724-731. PubMed ID: 33148663
[TBL] [Abstract][Full Text] [Related]
16. CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses.
Mei D; Luo Y; Wang Y; Gong J
Cancer Imaging; 2018 Dec; 18(1):52. PubMed ID: 30547844
[TBL] [Abstract][Full Text] [Related]
17. Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
Digumarthy SR; Padole AM; Gullo RL; Sequist LV; Kalra MK
Medicine (Baltimore); 2019 Jan; 98(1):e13963. PubMed ID: 30608433
[TBL] [Abstract][Full Text] [Related]
18. Can CT Radiomics Detect Acquired T790M Mutation and Predict Prognosis in Advanced Lung Adenocarcinoma With Progression After First- or Second-Generation EGFR TKIs?
Yang X; Fang C; Li C; Gong M; Yi X; Lin H; Li K; Yu X
Front Oncol; 2022; 12():904983. PubMed ID: 35875167
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning-Based Radiomics for Prediction of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma.
Lu J; Ji X; Wang L; Jiang Y; Liu X; Ma Z; Ning Y; Dong J; Peng H; Sun F; Guo Z; Ji Y; Xing J; Lu Y; Lu D
Dis Markers; 2022; 2022():2056837. PubMed ID: 35578691
[TBL] [Abstract][Full Text] [Related]
20. EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma.
Chen Q; Li Y; Cheng Q; Van Valkenburgh J; Sun X; Zheng C; Zhang R; Yuan R
Onco Targets Ther; 2022; 15():597-608. PubMed ID: 35669165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]